Aerie Pharmaceuticals announced that the FDA has approved their once-daily glaucoma drop, Rhopressa, for lowering IOP in patients with open-angle glaucoma or ocular hypertension. Source: AAO
This week a crescent-shaped burn highlights the need for protective eyewear during solar eclipses, and fungal infections fall prey to a rose-colored eyedrop combined with green fluorescent light. Source: AAO
This cross-sectional study examines the utility of strabismus goggles, which feature a head-fixed laser target display and liquid crystal display shutters, for binocular dissociation. Source: AAO
A recent alteration in the formulation of preservative-free epinephrine could lead to a shortage of mydriatic agents for ophthalmologists, according to an alert issued by the American Society of Cataract and Refractive Surgery (ASCRS). Source: AAO
This is the largest study to examine long-term outcomes following allogenic ocular surface stem cell transplantation for limbal stem cell deficiency. Source: AAO
The FDA has expanded the indication for Omidria, a mydriatic and NSAID combination agent, to include use in pediatric patients from birth through 17 years. Source: AAO
This study reviews the bacterial origins and potential causative factors of preseptal cellulitis and abscesses involving the eyebrow. Source: AAO
Findings from this retrospective study suggest that patients with initial suboptimal response to an intravitreal corticosteroid implant may continue to have a suboptimal response on long-term follow-up. Source: AAO
This week researchers unveil a temperature-sensitive sealant that could buy time for open-globe injuries, and an omega-3-supplemented eye drop gets approved in Europe. Source: AAO
Physicians may soon have a steroid alternative in their uveitis treatment toolkit: A phase 2 trial finds that the new aldehyde trap drug reproxalap (Aldeyra Therapeutics) is noninferior to prednisolone acetate (Pred Forte) at reducing ocular inflammation in patients with noninfectious anterior uveitis. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
